Merck MRK
NYSE MRK
$144.70 -2.83 (-1.92%)
As of: Sep 10, 2026 · 3:59 PM EDT

Merck (MRK) FCF Payout Ratio (2009 - 2026)

Merck's (MRK) quarterly FCF Payout Ratio came in at 0.48 in Q2 2026, down 41.69% year-over-year from 0.82 in Q2 2025, and down 33.41% quarter-over-quarter from 0.72 in Q1 2026.

Analysis

Merck (MRK) FCF Payout Ratio (2009 - 2026) Analysis & Trends

Merck (MRK) has reported FCF Payout Ratio for 18 consecutive years, with 0.48 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, FCF Payout Ratio fell 41.69% year-over-year to 0.48 in Q2 2026; TTM through Jun 2026 was 0.52, a 5.3% decrease from a year earlier, with the FY2025 full-year figure at 0.66, up 52.68% from the prior year.
  • FCF Payout Ratio was 0.48 for Q2 2026 at Merck, down from 0.72 in the prior quarter.
  • Over five years, FCF Payout Ratio peaked at 5.58 in Q1 2023 and troughed at 2.49 in Q4 2023.
  • A 5-year average of 0.75 and a median of 0.55 in 2022 frame the typical range for FCF Payout Ratio.
  • The widest YoY moves for FCF Payout Ratio: up 1108.06% in 2023, down 567.33% in 2023.
  • Over 5 years, FCF Payout Ratio stood at 0.53 in 2022, then tumbled by 567.33% to 2.49 in 2023, then surged by 131.15% to 0.78 in 2024, then surged by 42.51% to 1.11 in 2025, then slumped by 56.71% to 0.48 in 2026.
  • The last three FCF Payout Ratio figures came in at 0.48 (Q2 2026), 0.72 (Q1 2026), and 1.11 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Cover (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn 0.44
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn 0.99
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn 0.48
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn 0.46
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn 8.12
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn 1.77
7 Revolution Medicines 42.88 Bn 42.88 Bn - -
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn -
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn -
10 Neurocrine Biosciences 15.82 Bn 15.43 Bn 935.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.48
Mar 31, 2026 0.72
Dec 31, 2025 1.11
Sep 30, 2025 0.30
Jun 30, 2025 0.82
Mar 31, 2025 1.75
Dec 31, 2024 0.78
Sep 30, 2024 0.23
Jun 30, 2024 0.41
Mar 31, 2024 0.87
Dec 31, 2023 -2.49
Sep 30, 2023 0.27
Jun 30, 2023 0.69
Mar 31, 2023 5.58
Dec 31, 2022 0.53
Sep 30, 2022 0.39
Jun 30, 2022 0.56
Mar 31, 2022 0.46
Dec 31, 2021 0.42
Sep 30, 2021 0.45